Vascular  	Vascular  	 JJ	B-NP
calcification  	calcification  	 NN	I-NP
and  	and  	 CC	O
subendocardial  	subendocardial  	 JJ	B-NP
ischemia  	ischemia  	 NN	I-NP
in  	in  	 IN	O
hemodialysis  	hemodialysis  	 JJ	B-NP
patients 	patients 	 NNS	I-NP
:  	:  	 :	O
a  	a  	 DT	O
new  	new  	 JJ	O
morpho-functional  	morpho-functional  	 JJ	B-NP
score  	score  	 NN	I-NP
to  	to  	 TO	O
assess  	assess  	 VB	O
cardiovascular  	cardiovascular  	 JJ	B-NP
risk 	risk 	 NN	I-NP
:  	:  	 :	O
the  	the  	 DT	O
Solofra  	Solofra  	 JJ	B-NP
score  	score  	 NN	I-NP
ESRD  	ESRD  	 NNP	I-NP
( 	( 	 -LRB-	O
end-stage  	end-stage  	 JJ	B-NP
renal  	renal  	 JJ	I-NP
disease 	disease 	 NN	I-NP
)  	)  	 -RRB-	O
patients  	patients  	 NNS	O
have  	have  	 VBP	O
a  	a  	 DT	O
high  	high  	 JJ	O
cardiovascular  	cardiovascular  	 JJ	B-NP
mortality  	mortality  	 NN	I-NP
risk 	risk 	 NN	I-NP
.  	.  	 .	O
A  	A  	 DT	O
morphofunctional  	morphofunctional  	 JJ	B-NP
approach  	approach  	 NN	I-NP
of  	of  	 IN	I-NP
vascular  	vascular  	 JJ	I-NP
calcifications  	calcifications  	 NN	I-NP
and  	and  	 CC	O
myocardial  	myocardial  	 JJ	B-NP
perfusion  	perfusion  	 NN	I-NP
is  	is  	 VBZ	O
needed  	needed  	 VBN	O
for  	for  	 IN	O
the  	the  	 DT	O
management  	management  	 NN	O
of  	of  	 IN	O
ESRD  	ESRD  	 NNP	B-NP
patients 	patients 	 NNS	I-NP
.  	.  	 .	O
We  	We  	 PRP	O
used  	used  	 VBD	O
SEVR  	SEVR  	 NNP	B-NP
( 	( 	 -LRB-	O
sub-endocardial  	sub-endocardial  	 JJ	B-NP
viability  	viability  	 NN	I-NP
ratio 	ratio 	 NN	I-NP
)  	)  	 -RRB-	O
and  	and  	 CC	O
Kauppila  	Kauppila  	 NNP	B-NP
score  	score  	 NN	I-NP
from  	from  	 IN	O
the  	the  	 DT	O
dialysis  	dialysis  	 NN	B-NP
population  	population  	 NN	I-NP
of  	of  	 IN	I-NP
the  	the  	 DT	I-NP
Independent  	Independent  	 JJ	I-NP
study  	study  	 NN	I-NP
to  	to  	 TO	O
create  	create  	 VB	O
a  	a  	 DT	O
new  	new  	 JJ	O
morpho-functional  	morpho-functional  	 JJ	B-NP
score  	score  	 NN	I-NP
to  	to  	 TO	O
assess  	assess  	 VB	O
cardiovascular  	cardiovascular  	 JJ	B-NP
risk  	risk  	 NN	I-NP
in  	in  	 IN	O
this  	this  	 DT	O
population  	population  	 NN	O
( 	( 	 -LRB-	O
the  	the  	 DT	O
Solofra  	Solofra  	 JJ	B-NP
score 	score 	 NN	I-NP
) 	) 	 -RRB-	O
.  	.  	 .	O
184  	184  	 CD	O
patients  	patients  	 NNS	O
were  	were  	 VBD	O
followed-up  	followed-up  	 JJ	O
for  	for  	 IN	O
36  	36  	 CD	O
months 	months 	 NNS	O
.  	.  	 .	O
A  	A  	 DT	O
side  	side  	 NN	O
lumbar  	lumbar  	 NN	O
X-ray  	X-ray  	 NN	B-NP
was  	was  	 VBD	O
performed  	performed  	 VBN	O
to  	to  	 TO	O
assess  	assess  	 VB	O
vascular  	vascular  	 JJ	B-NP
calcifications  	calcifications  	 NN	I-NP
of  	of  	 IN	O
lumbar  	lumbar  	 JJ	O
aorta  	aorta  	 NNS	B-NP
using  	using  	 VBG	O
the  	the  	 DT	O
Kauppila  	Kauppila  	 JJ	B-NP
score 	score 	 NN	I-NP
.  	.  	 .	O
Central  	Central  	 JJ	O
aortic  	aortic  	 JJ	O
pressure  	pressure  	 NN	O
and  	and  	 CC	O
pulse  	pulse  	 JJ	B-NP
velocity  	velocity  	 NN	I-NP
wave  	wave  	 NN	I-NP
( 	( 	 -LRB-	O
PWV 	PWV 	 NNP	B-NP
)  	)  	 -RRB-	O
were  	were  	 VBD	O
assessed  	assessed  	 VBN	O
at  	at  	 IN	O
the  	the  	 DT	O
carotid  	carotid  	 JJ	B-NP
artery  	artery  	 NN	I-NP
site 	site 	 NN	I-NP
.  	.  	 .	O
Myocardial  	Myocardial  	 JJ	B-NP
perfusion  	perfusion  	 NN	I-NP
was  	was  	 VBD	O
estimated  	estimated  	 VBN	O
with  	with  	 IN	O
SEVR 	SEVR 	 NNP	B-NP
.  	.  	 .	O
Independent  	Independent  	 JJ	B-NP
risk  	risk  	 NN	I-NP
mortality  	mortality  	 NN	I-NP
factors  	factors  	 NNS	I-NP
were  	were  	 VBD	O
identified  	identified  	 VBN	O
with  	with  	 IN	O
univariate  	univariate  	 JJ	B-NP
regression  	regression  	 JJ	I-NP
analysis  	analysis  	 NN	I-NP
( 	( 	 -LRB-	O
p  	p  	 CD	O
< 	< 	 SYM	O
0.01 	0.01 	 CD	O
) 	) 	 -RRB-	O
;  	;  	 :	O
significance  	significance  	 NN	B-NP
was  	was  	 VBD	O
defined  	defined  	 VBN	O
as  	as  	 IN	O
p  	p  	 CD	O
< 	< 	 SYM	O
0.05 	0.05 	 CD	O
.  	.  	 .	O
Kauppila  	Kauppila  	 JJ	B-NP
score  	score  	 NN	I-NP
was  	was  	 VBD	O
13±10 	13±10 	 CD	O
( 	( 	 -LRB-	O
range  	range  	 NN	O
0-24 	0-24 	 CD	O
) 	) 	 -RRB-	O
;  	;  	 :	O
PWV  	PWV  	 NNP	B-NP
was  	was  	 VBD	O
9.5±4  	9.5±4  	 CD	O
m 	m 	 CD	B-NP
/ 	/ 	 CD	I-NP
sec 	sec 	 NNS	I-NP
;  	;  	 :	O
basal  	basal  	 JJ	B-NP
SEVR  	SEVR  	 NNP	I-NP
was  	was  	 VBD	O
1.3±0.9 	1.3±0.9 	 CD	O
.  	.  	 .	O
We  	We  	 PRP	O
observed  	observed  	 VBD	O
an  	an  	 DT	O
improvement  	improvement  	 NN	O
of  	of  	 IN	O
ROC  	ROC  	 NNP	O
curves  	curves  	 NN	O
for  	for  	 IN	O
SEVR  	SEVR  	 NNP	B-NP
and  	and  	 CC	O
Kauppila  	Kauppila  	 NNP	B-NP
score  	score  	 VBP	O
together  	together  	 RB	O
compared  	compared  	 VBN	O
to  	to  	 TO	O
the  	the  	 DT	O
ones  	ones  	 NNS	B-NP
for  	for  	 IN	I-NP
SEVR  	SEVR  	 NNP	I-NP
or  	or  	 CC	O
Kauppila  	Kauppila  	 NNP	B-NP
score  	score  	 VBP	O
alone 	alone 	 RB	O
.  	.  	 .	O
A  	A  	 DT	O
quantitative  	quantitative  	 JJ	B-NP
analysis  	analysis  	 NN	I-NP
of  	of  	 IN	I-NP
vascular  	vascular  	 JJ	I-NP
calcifications  	calcifications  	 NN	I-NP
should  	should  	 MD	O
be  	be  	 VB	O
associated  	associated  	 VBN	O
to  	to  	 TO	O
a  	a  	 DT	O
qualitative  	qualitative  	 JJ	B-NP
evaluation  	evaluation  	 NN	I-NP
of  	of  	 IN	I-NP
arterial  	arterial  	 JJ	I-NP
damage  	damage  	 NN	I-NP
to  	to  	 TO	O
better  	better  	 JJR	O
estimate  	estimate  	 NN	O
cardiovascular  	cardiovascular  	 JJ	B-NP
mortality  	mortality  	 NN	I-NP
risk  	risk  	 NN	I-NP
of  	of  	 IN	I-NP
ESRD  	ESRD  	 NNP	I-NP
patients 	patients 	 NNS	I-NP
.  	.  	 .	O
Further  	Further  	 JJ	B-NP
studies  	studies  	 NNS	I-NP
are  	are  	 VBP	O
needed  	needed  	 VBN	O
to  	to  	 TO	O
verify  	verify  	 VB	O
our  	our  	 PRP$	O
hypothesis 	hypothesis 	 NN	O
.  	.  	 .	O
